Skip to content

Drug interactions

Lonafarnib + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Moderate

Lonafarnib and Sofosbuvir-velpatasvir-voxilaprevir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a strong CYP3A inhibitor and may increase velpatasvir and voxilaprevir exposure. The clinical consequence may include more adverse effects such as liver enzyme elevations.

What this interaction means in plain words

Lonafarnib and Sofosbuvir-velpatasvir-voxilaprevir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lonafarnib belongs to Miscellaneous; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Low

Why it happens

Lonafarnib inhibits CYP3A4, which reduces metabolism of velpatasvir and voxilaprevir.

What to do

Monitor for adverse effects and liver enzymes. Consider an alternative HCV regimen if tolerability problems arise.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lonafarnib and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lonafarnib with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as moderate. Lonafarnib and Sofosbuvir-velpatasvir-voxilaprevir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lonafarnib is a strong CYP3A inhibitor and may increase velpatasvir and voxilaprevir exposure. The clinical consequence may include more adverse effects such as liver enzyme elevations.

How serious is the interaction between Lonafarnib and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for adverse effects and liver enzymes. Consider an alternative HCV regimen if tolerability problems arise.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in